Andrianova Izabella, Hayes Vincent, Litvinov Rustem I, Nagaswami Chandrasekaran, Arepally Gowthami M, Cines Douglas B, Poncz Mortimer, Weisel John W, Rauova Lubica
Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA; Department of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
J Thromb Haemost. 2025 May;23(5):1562-1575. doi: 10.1016/j.jtha.2025.01.014. Epub 2025 Feb 9.
Heparin-induced thrombocytopenia (HIT) is an antibody-mediated disorder associated with thrombosis developing in response to anticoagulation with heparin. Monocytes targeted by HIT antibodies contribute to the prothrombotic state, but structural and functional alterations of the activated monocytes have not been described.
To study morphologic and functional changes in monocytes caused by HIT antibodies interacting with membrane-associated platelet factor 4 (PF4) in vitro.
THP-1, isolated human, or FcγRIIA-positive and FcγRIIA-negative mouse monocytes were incubated with recombinant human PF4 and/or anti-PF4/heparin antibodies followed by scanning electron microscopy and confocal microscopy.
Binding of PF4 to monocytes induced formation of "knobs" ∼150 nm in size that protruded from the cell surface. Addition of pathogenic HIT-like monoclonal antibodies (KKO) caused profound remodeling of the cell membrane and time-dependent formation and clustering of KKO/PF4/glycosaminoglycan complexes into large "blebs" ranging in size from 500 to 1200 nm. Dynamic confocal microscopy revealed formation of monocyte-derived microvesicles in response to PF4 and KKO. In contrast, RTO, a monoclonal antibody that blocks PF4 oligomerization and prevents thrombocytopenia/thrombosis in an animal HIT model, inhibited PF4-induced modification of monocyte surfaces. Comparing monocytes from transgenic mice expressing hFcγRIIA to wild-type mice lacking FcγRIIA indicated that bleb formation results from clustering of knobs caused by bivalent HIT antibodies through crosslinking of FcγRIIA.
Binding of pathogenic HIT antibodies to PF4-containing antigenic complexes assembled on the monocyte surface promotes large-scale plasma membrane remodeling as part of cell activation through the FcγRIIA receptors, resulting in the release of procoagulant microvesicles, which together may contribute to thrombosis in HIT.
肝素诱导的血小板减少症(HIT)是一种抗体介导的疾病,与肝素抗凝治疗后发生的血栓形成有关。被HIT抗体靶向的单核细胞促成了血栓前状态,但活化单核细胞的结构和功能改变尚未见描述。
研究体外HIT抗体与膜相关血小板因子4(PF4)相互作用引起的单核细胞形态和功能变化。
将THP-1、分离的人单核细胞或FcγRIIA阳性和FcγRIIA阴性小鼠单核细胞与重组人PF4和/或抗PF4/肝素抗体孵育,随后进行扫描电子显微镜和共聚焦显微镜检查。
PF4与单核细胞结合诱导形成大小约为150 nm的“瘤状物”,从细胞表面突出。添加致病性HIT样单克隆抗体(KKO)导致细胞膜发生深刻重塑,KKO/PF4/糖胺聚糖复合物随时间形成并聚集为大小在500至1200 nm之间的大“泡状突起”。动态共聚焦显微镜显示,PF4和KKO可诱导单核细胞衍生微泡的形成。相比之下,RTO是一种单克隆抗体,可阻断PF4寡聚化并预防动物HIT模型中的血小板减少症/血栓形成,它可抑制PF4诱导的单核细胞表面修饰。将表达hFcγRIIA的转基因小鼠的单核细胞与缺乏FcγRIIA的野生型小鼠的单核细胞进行比较表明,泡状突起的形成是由二价HIT抗体通过FcγRIIA交联导致瘤状物聚集引起的。
致病性HIT抗体与单核细胞表面组装的含PF4抗原复合物结合,促进大规模质膜重塑,这是通过FcγRIIA受体进行细胞活化的一部分,导致促凝微泡释放,这可能共同促成HIT中的血栓形成。